Why Veru, Invitae And More Are Moving Today

Community Health Systems CYH shares are trading higher after the company reported better-than-expected fourth-quarter sales results.

Community Health Systems is the largest publicly owned hospital operator in the United States. The company owns or leases over 100 general acute-care hospitals located in nonurban and urban markets. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Community Health Systems shares traded down 7.47% to $8.55. The stock has a 52-week high of $11.45 and a 52-week low of $2.25.

Veru VERU shares are trading lower after the company priced its 6.451 million shares common stock offering at $15.50 per share.

Veru is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers.

Veru shares were trading down 9.30% at $15.61. The stock has a 52-week high of $24.57 and a 52-week low of $2.30.

Molecular Templates MTEM shares are trading lower after the company priced its 6 million shares common stock offering at $12.65 per share.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.

Molecular Templates shares were trading down 4.41% at $13.02. The stock has a 52-week high of $19.12 and a 52-week low of $7.51.

Invitae Corp NVTA shares are trading higher after the company reported better-than-expected fourth-quarter sales results.

Ladenburg Thalmann upgraded the stock from Neutral to Buy and raised its price target from $46.50 to $58 per share.

Invitae is medical genetics company and Singular Bio is a privately held company developing single-molecule detection technology that allows expanded use of high-quality, cell-free, nucleic acid analysis, initially for application in non-invasive prenatal screening (NIPS).

Invitae shares were trading up 1.02% at $48.35. The stock has a 52-week high of $61.59 and a 52-week low of $7.42.

Posted In: NewsSmall CapMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...